載入...
An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision
Axial spondyloarthritis (axSpA) is a group of debilitating, chronic, rheumatic conditions characterized by inflammation and new bone formation, mainly involving the spine and the sacroiliac joints. The lack of biomarkers in axSpA is well known. Despite significant treatment advances in recent years...
Na minha lista:
| 發表在: | Ther Adv Musculoskelet Dis |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7315656/ https://ncbi.nlm.nih.gov/pubmed/32636944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X20934277 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|